MA-to-MA switching among dually eligible beneficiaries rose sharply from 2016 to 2022, AJMC study author Grace Mackleby, PhD, found.
|Podcasts|December 4, 2018
Nationwide Children's Pediatrician Alex Kemper Discusses Review of ADHD Therapies
Alex R. Kemper, MD, MPH, MS, discusses the key findings from a comparative effectiveness review called Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents from the Agency for Healthcare Research and Quality.
Advertisement
Attention deficit hyperactivity disorder (ADHD) is one of the most common conditions in childhood and is often treated by primary care providers. Earlier this year, the Agency for Healthcare Research and Quality published a comparative effectiveness review called Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents.
The lead author of the report, Alex R. Kemper, MD, MPH, MS, discussed the key findings with Managed Care Cast. Kemper, a board-certified pediatrician and chief of the division of ambulatory pediatrics at Nationwide Children’s Hospital, talked about what doctors and families need to know in order to understand the best treatment options.
iTunes:
TuneIn:
Stitcher:
Listen above or through one of these podcast services:
Read more about ADHD here:
Advertisement
Related to this article
This moves the noncovalent BTK inhibitor into the first-line setting for certain adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.
CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
This week in health equity and access: PMOS diagnosis, HIV lung cancer screening, transplant access, atopic dermatitis care, and value-based oncology.
Phase 3 wins for ianalumab and dazodalibep bring targeted therapies closer for Sjögren disease as patients face diagnostic delays and high costs.
Patch testing in Malaysia finds contact dermatitis drivers in chronic hand eczema—nickel and fragrance allergy lead, while cosmetics raise polysensitization risk.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
Advertisement
Advertisement
Trending on AJMC
1
Pharmacists Bridge the Vaccine Trust Gap as COVID-19 Persists
2
Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer
3
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
4
Lung Cancer Screening Lags for People With HIV as Eligibility Triples
5